441 related articles for article (PubMed ID: 28685691)
1. Metabolomics Applications in Precision Medicine: An Oncological Perspective.
Puchades-Carrasco L; Pineda-Lucena A
Curr Top Med Chem; 2017; 17(24):2740-2751. PubMed ID: 28685691
[TBL] [Abstract][Full Text] [Related]
2. Oncometabolomics in cancer research.
Gupta S; Chawla K
Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
[TBL] [Abstract][Full Text] [Related]
3. Emerging applications of metabolomics in drug discovery and precision medicine.
Wishart DS
Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
[TBL] [Abstract][Full Text] [Related]
4. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
6. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics and Personalized Medicine.
Koen N; Du Preez I; Loots du T
Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
[TBL] [Abstract][Full Text] [Related]
8. New opportunities from the cancer metabolome.
Aboud OA; Weiss RH
Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
[TBL] [Abstract][Full Text] [Related]
9. G-DOC: a systems medicine platform for personalized oncology.
Madhavan S; Gusev Y; Harris M; Tanenbaum DM; Gauba R; Bhuvaneshwar K; Shinohara A; Rosso K; Carabet LA; Song L; Riggins RB; Dakshanamurthy S; Wang Y; Byers SW; Clarke R; Weiner LM
Neoplasia; 2011 Sep; 13(9):771-83. PubMed ID: 21969811
[TBL] [Abstract][Full Text] [Related]
10. Precision Cardio-Oncology.
Dreyfuss AD; Bravo PE; Koumenis C; Ky B
J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine Approach in Prostate Cancer.
Assadi M; Jokar N; Ghasemi M; Nabipour I; Gholamrezanezhad A; Ahmadzadehfar H
Curr Pharm Des; 2020; 26(31):3783-3798. PubMed ID: 32067601
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics: Applications and Promise in Mycobacterial Disease.
Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
[TBL] [Abstract][Full Text] [Related]
13. Omics sciences and precision medicine in lung cancer.
Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics Biomarkers for Precision Psychiatry.
Shih PB
Adv Exp Med Biol; 2019; 1161():101-113. PubMed ID: 31562625
[TBL] [Abstract][Full Text] [Related]
15. Applications of Metabolomics in Cancer Studies.
Armitage EG; Ciborowski M
Adv Exp Med Biol; 2017; 965():209-234. PubMed ID: 28132182
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
[TBL] [Abstract][Full Text] [Related]
17. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
18. Applications of metabolomics to study cancer metabolism.
Kaushik AK; DeBerardinis RJ
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):2-14. PubMed ID: 29702206
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.
Wu X; Wang Z; Luo L; Shu D; Wang K
Front Med Technol; 2022; 4():1065506. PubMed ID: 36688143
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
